NCT06413680
A First-In Human (FIH) Trial to Find Out if REGN10597 is Safe and How Well it Works for Adult Participants With Advanced Solid Organ Malignancies No drug interventions treatment 1 / 2 not_yet_recruiting NCT05706129
A Study to Assess Safety, Tolerability and Imaging Characteristics of [68Ga]Ga-DPI-4452 and to Assess Safety, Tolerability, and Efficacy of [177Lu]Lu-DPI-4452 in Participants With Unresectable Locally Advanced or Metastatic Solid Tumors treatment 1 / 2 recruiting NCT01672775
A Study to Assess the Safety, Pharmacokinetics and Effectiveness of AGS-16C3F Monotherapy in Subjects With Renal Cell Carcinoma (RCC) of Clear Cell or Papillary Histology treatment 1 completed NCT04504669
First Time in Human Study of AZD8701 With or Without Durvalumab in Participants With Advanced Solid Tumours treatment 1 active_not_recruiting NCT03972657
A Trial to Find Out if REGN5678 is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors treatment 1 / 2 recruiting NCT03634540
A Trial of Belzutifan (PT2977, MK-6482) in Combination With Cabozantinib in Patients With Clear Cell Renal Cell Carcinoma (ccRCC) (MK-6482-003) treatment 2 active_not_recruiting NCT06026410
KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors treatment 1 recruiting NCT02771626
Study CB-839 in Combination With Nivolumab in Patients With Melanoma, Clear Cell Renal Cell Carcinoma (ccRCC) and Non-Small Cell Lung Cancer (NSCLC) treatment 1 / 2 terminated NCT02022787
Value of Various Chemokines in the Detection and Follow up of RCC No drug interventions Not Available Not Available unknown_status NCT05239533
Study of Nivolumab in Combination With 177Lu-girentuximab for Kidney Cancer treatment 2 recruiting NCT04779151
Basket Trial Exploring the Efficacy and Safety of the Combination of Niraparib and Dostarlimab treatment 2 suspended NCT02607553
Safety and Activity of G-202 in Patients With Clear Cell Renal Cell Carcinoma That Expresses PSMA treatment 2 completed NCT04374877
Study of CHS-388 (Formerly Known as SRF388) in Patients With Advanced Solid Tumors treatment 1 recruiting NCT00890747
Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral Therapy treatment 1 completed NCT05432947
68Ga-P16-093 and 18F-FDG PET/CT Imaging in the Same Group of Clear Cell Renal Cell Carcinoma Patients diagnostic Not Available completed NCT03987698
Study of PD-1 Inhibitor Combination With Autologous Cell Immunotherapy in the Metastatic Renal Cell Carcinoma treatment 2 unknown_status NCT05879497
68Ga-NY104 PET/CT in Patients With Metastasis/Recurrence Clear Cell Renal Cell Carcinoma Suspicion No drug interventions diagnostic 2 recruiting NCT02247583
Investigating Patient Satisfaction With Oral Anti-Cancer Treatment No drug interventions Not Available Not Available completed NCT04169711
Study of ARO-HIF2 in Patients With Advanced Clear Cell Renal Cell Carcinoma No drug interventions treatment 1 completed NCT05861778
Evaluation of 89Zr-TLX250 PET/CT in Chinese Patients With Indeterminate Renal Masses or Suspected Recurrent Renal Clear Cell Carcinoma diagnostic 1 completed NCT04810078
A Study of Subcutaneous Nivolumab Versus Intravenous Nivolumab in Participants With Previously Treated Clear Cell Renal Cell Carcinoma That is Advanced or Has Spread treatment 3 recruiting NCT00199888
Safety Study With the Antibody, cG250, and Isotope, 124-Iodine, to Diagnose Patients With Renal Masses. No drug interventions diagnostic 1 completed NCT01582009
Panobinostat and Everolimus in Treating Patients With Metastatic or Unresectable Renal Cell Cancer That Does Not Respond to Treatment With Sunitinib Malate or Sorafenib Tosylate treatment 1 / 2 terminated NCT04370509
Pembrolizumab With or Without Axitinib for Treatment of Locally Advanced or Metastatic Clear Cell Kidney Cancer in Patients Undergoing Surgery treatment 2 active_not_recruiting NCT05214885
Novel Biomarkers of Hypoxia and Metabolism in Clear Cell Renal Cell Carcinoma No drug interventions Not Available Not Available recruiting NCT05728515
A Small-molecule Carbonic Anhydrase IX Targeting PET Tracer in Clear Cell Renal Cell Carcinoma No drug interventions diagnostic 0 completed NCT06052852
Study of BDC-3042 as Single Agent and in Combination With Cemiplimab in Patients With Advanced Malignancies treatment 1 / 2 recruiting NCT01243359
Sunitinib Malate and Bevacizumab in Treating Patients With Kidney Cancer or Advanced Solid Malignancies treatment 1 completed NCT04989959
[18F]PT2385 PET/CT in Patients With Renal Cell Carcinoma diagnostic 1 recruiting NCT03149159
Investigator-Initiated Trial of Combined Ipilimumab, Nivolumab and Stereotactic Radiation in Patients With Metastatic Clear-Cell RCC (ccRCC) Who Have Failed Treatment With Single-Agent Nivolumab treatment 2 withdrawn NCT06242470
A Study of MGC026 in Participants With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT01069770
Neoadjuvant Sunitinib Treatment for Metastatic Clear Cell Renal Cell Carcinoma (RCC) treatment 2 unknown_status NCT05520099
Observational Basket Trial to Collect Tissue to Train and Validate a Live Tumor Diagnostic Platform No drug interventions Not Available Not Available recruiting NCT00005799
Fludarabine Phosphate, Low-Dose Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer treatment Not Available completed NCT03592199
Biomarker Study of Pts With Metastatic ccRCC Undergoing Sequential Therapy With 1st Line Sunitinib and 2nd Line Axitinib treatment 2 unknown_status NCT03875313
Study of CB-839 (Telaglenastat) in Combination With Talazoparib in Patients With Solid Tumors treatment 1 / 2 terminated NCT02595918
Nivolumab in Treating Patients With High-Risk Kidney Cancer Before Surgery treatment 1 terminated NCT03849118
89Zr-TLX250 for PET/CT Imaging of ccRCC- ZIRCON Study No drug interventions diagnostic 3 completed NCT05536141
A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid Tumors treatment 1 recruiting NCT02210117
Nivolumab With or Without Bevacizumab or Ipilimumab Before Surgery in Treating Patients With Metastatic Kidney Cancer That Can Be Removed by Surgery treatment 0 active_not_recruiting NCT06088134
Contrast-enhanced CT-based Deep Learning Model for Preoperative Prediction of Disease-free Survival (DFS) in Localized Clear Cell Renal Cell Carcinoma (ccRCC) No drug interventions Not Available Not Available recruiting NCT04995016
Pembrolizumab and Axitinib as Neoadjuvant Therapy for Locally Advanced Non-metastatic Clear Cell Renal Cell Carcinoma treatment 2 unknown_status NCT03308396
Study of Durvalumab and Guadecitabine in Advanced Kidney Cancer treatment 1 / 2 active_not_recruiting NCT00078858
Mycophenolate Mofetil and Cyclosporine in Reducing Graft-Versus-Host Disease in Patients With Hematologic Malignancies or Metastatic Kidney Cancer Undergoing Donor Stem Cell Transplant treatment 1 / 2 completed NCT01198158
Everolimus With or Without Bevacizumab in Treating Patients With Advanced Kidney Cancer That Progressed After First-Line Therapy treatment 3 terminated NCT05119335
A Study of NKT2152, a HIF2α Inhibitor, in Patients With Advanced Clear Cell Renal Cell Carcinoma No drug interventions treatment 1 / 2 recruiting NCT00499135
Sunitinib Malate in Treating Patients With Unresectable or Metastatic Kidney Cancer or Other Advanced Solid Tumors treatment 1 completed NCT02667886
Trial of X4P-001 in Participants With Advanced Renal Cell Carcinoma treatment 1 / 2 completed NCT02626130
Tremelimumab With or Without Cryoablation in Treating Patients With Metastatic Kidney Cancer treatment 0 completed NCT03035630
Sunitinib Followed by Avelumab or the Reverse for Metastatic Renal Cell Carcinoma treatment 2 withdrawn NCT03473730
Daratumumab in Treating Patients With Muscle Invasive Bladder Cancer or Metastatic Kidney Cancer treatment 0 active_not_recruiting NCT05121948
A Study of HC-7366 to Establish the Maximum Tolerated Dose (MTD) and Recommended Phase 2 Dose (RP2D) No drug interventions treatment 1 terminated NCT01575548
Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer Who Have No Evidence of Disease After Surgery treatment 3 active_not_recruiting NCT03108066
MK-3795 (PT2385) for the Treatment of Von Hippel-Lindau Disease-Associated Clear Cell Renal Cell Carcinoma (MK-3795-003) treatment 2 completed NCT06480565
A Phase 1/2 Trial of ADI-270 in ccRCC treatment 1 / 2 not_yet_recruiting NCT00027820
Total-Body Irradiation and Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer treatment 1 / 2 completed NCT03185182
Diagnostic Imaging for Clear Cell Renal Cell Carcinoma diagnostic 2 terminated NCT06090331
89Zr-DFO-girentuximab Expanded Access Program (EAP) No drug interventions Not Available Not Available available NCT04958473
A Study of Sintilimab in Combination With Axitinib in Advanced Renal Cell Cancer treatment 2 not_yet_recruiting NCT06049576
Nivolumab and Ipilimumab With and Without Camu Camu for the Treatment of Patients With Metastatic Renal Cell Carcinoma treatment 1 recruiting NCT06519760
68Ga-C1 PET/ CT Imaging in Clear Cell Renal Cell Carcinoma No drug interventions diagnostic Not Available recruiting NCT00126594
Sorafenib Tosylate With or Without Recombinant Interferon Alfa-2b in Treating Patients With Metastatic Kidney Cancer treatment 2 completed NCT00303862
AZD2171 in Treating Patients With Refractory Metastatic Kidney Cancer treatment 2 terminated NCT00602862
Effect of Sorafenib on ccRCC Uptake of Radiolabeled Bevacizumab or cG250 basic_science Not Available completed NCT01727089
Bevacizumab With or Without TRC105 in Treating Patients With Metastatic Kidney Cancer treatment 2 completed NCT05086692
A Beta-only IL-2 ImmunoTherapY Study treatment 1 / 2 recruiting NCT03163667
CB-839 With Everolimus vs. Placebo With Everolimus in Participants With Renal Cell Carcinoma (RCC) treatment 2 completed NCT05199272
A Phase 1/2a Study of 23ME-00610 in Patients With Advanced Solid Malignancies No drug interventions treatment 1 / 2 active_not_recruiting NCT02700568
Axitinib in Metastatic Renal Cell Carcinoma Patients With Favorable Prognostic Factors treatment 2 completed NCT04053855
Evaluation of Urinary Exosomes Presence From Clear Cell Renal Cell Carcinoma No drug interventions Not Available Not Available recruiting NCT06195150
Overtaking Intra and Inter Tumoral Heterogeneity In Von Hippel-Lindau Related Renal Cancer No drug interventions Not Available Not Available recruiting NCT04071223
Testing the Addition of a New Anti-cancer Drug, Radium-223 Dichloride, to the Usual Treatment (Cabozantinib) for Advanced Renal Cell Cancer That Has Spread to the Bone, RadiCaL Study treatment 2 recruiting NCT03438708
Prior Axitinib as a Determinant of Outcome of Renal Surgery treatment 2 unknown_status NCT06339138
Identification of Novel High Quality Methylated DNA Markers in Renal Tumors: Whole Methylome Discovery, Tissue Validation, and Feasibility Testing In Blood and Urine, The INQUIRE Study No drug interventions Not Available Not Available recruiting NCT02974738
A Trial of Belzutifan (PT2977, MK-6482) Tablets In Patients With Advanced Solid Tumors (MK-6482-001) treatment 1 active_not_recruiting NCT00126503
Sorafenib Tosylate and Bevacizumab in Treating Patients With Advanced Kidney Cancer treatment 1 / 2 completed NCT00378703
Bevacizumab, Sorafenib Tosylate, and Temsirolimus in Treating Patients With Metastatic Kidney Cancer treatment 2 completed NCT00182702
Ixabepilone in Treating Patients With Metastatic, Recurrent, or Unresectable Kidney Cancer treatment 2 completed NCT02581384
Stereotactic Body Radiotherapy (SBRT) for Pulmonary Metastases in Ewing Sarcoma, Rhabdomyosarcoma, and Wilms Tumors No drug interventions treatment 1 / 2 terminated NCT01791387
1st-line Activity of Dovitinib and Correlation With Genetic Changes in RCC treatment 2 unknown_status NCT01826877
Autologous Dendritic Cells in Treating Patients With Metastatic Kidney Cancer No drug interventions treatment 1 completed NCT00326898
Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery treatment 3 completed NCT04006405
AURORAX-0087A: GAG Scores for Surveillance of Recurrence in Leibovich Points ≥5 Non-metastatic ccRCC No drug interventions Not Available Not Available recruiting NCT01684397
Pazopanib Hydrochloride and Bevacizumab in Treating Patients With Previously Untreated Metastatic Kidney Cancer treatment 1 / 2 active_not_recruiting NCT03829111
CBM588, Nivolumab, and Ipilimumab in Treating Patients With Stage IV or Advanced Kidney Cancer treatment 1 completed NCT01038778
Entinostat in Combination With Aldesleukin in Treating Patients With Metastatic Kidney Cancer treatment 1 / 2 active_not_recruiting NCT01943188
Stereotactic Body Radiation Therapy and T-Cell Infusion in Treating Patients With Metastatic Kidney Cancer treatment 1 terminated NCT03334409
Pazopanib Hydrochloride With or Without Ascorbic Acid in Treating Patients With Kidney Cancer That Is Metastatic or Cannot Be Removed by Surgery treatment 2 terminated NCT03092856
Axitinib With or Without Anti-OX40 Antibody PF-04518600 in Treating Patients With Metastatic Kidney Cancer treatment 2 active_not_recruiting NCT00335556
Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors treatment 2 completed NCT03284385
Testing AZD1775 in Advanced Solid Tumors That Have a Mutation Called SETD2 treatment 2 active_not_recruiting NCT02118337
A Phase 1/2, Open-label Study to Evaluate the Safety and Antitumor Activity of MEDI0680 (AMP-514) in Combination With Durvalumab Versus Nivolumab Monotherapy in Participants With Select Advanced Malignancies treatment 1 / 2 completed NCT01599832
Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Measuring Effects of Pazopanib Hydrochloride in Patients With Metastatic Kidney Cancer diagnostic Not Available terminated NCT00126659
Sorafenib in Treating Patients Who Are Undergoing Surgery for Metastatic Kidney Cancer treatment 2 terminated NCT00324870
Vorinostat and Bevacizumab in Treating Patients With Unresectable or Metastatic Kidney Cancer treatment 1 / 2 completed NCT05433142
Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma No drug interventions treatment 1 recruiting NCT02885649
Enzalutamide Before Surgery in Treating Patients With Kidney Cancer treatment 0 terminated NCT00098618
Sorafenib and Interferon Alfa in Treating Patients With Locally Advanced or Metastatic Kidney Cancer treatment 2 terminated NCT05585034
Phase 1, First-in-human, Dose-finding and Expansion Study to Evaluate XmAb®808 in Combination With Pembrolizumab in Advanced Solid Tumors treatment 1 recruiting NCT05620134
Study of JK08 in Patients With Unresectable Locally Advanced or Metastatic Cancer treatment 1 / 2 recruiting NCT06138496
Cadonilimab Combination With Lenvatinib as Neoadjuvant Therapy for ccRCC treatment 2 recruiting NCT00193258
Bevacizumab, Erlotinib, and Imatinib in the Treatment of Advanced Renal Cell Carcinoma treatment 1 / 2 completed NCT01835158
Cabozantinib-s-malate or Sunitinib Malate in Treating Patients With Previously Untreated Locally Advanced or Metastatic Kidney Cancer treatment 2 completed NCT02628535
Safety Study of MGD009 in B7-H3-expressing Tumors No drug interventions treatment 1 terminated NCT01715935
Biomarkers Before and After Nephrectomy of Locally Advanced or Metastatic Renal Cell Carcinoma Treated With Everolimus Not Available 2 completed NCT02575222
Study of Neoadjuvant Nivolumab in Patients With Non-metastatic Stage II-IV Clear Cell Renal Cell Carcinoma treatment 1 completed NCT01158222
Sunitinib Malate in Treating Patients With Previously Untreated Metastatic Kidney Cancer treatment 2 completed NCT05935748
Ph2 Study NKT2152 With Palbociclib & Sasanlimab in Subjects With Advanced Clear Cell Renal Cell Carcinoma (ccRcc) treatment 2 recruiting NCT03793166
Immunotherapy With Nivolumab and Ipilimumab Followed by Nivolumab or Nivolumab With Cabozantinib for Patients With Advanced Kidney Cancer, The PDIGREE Study treatment 3 active_not_recruiting NCT02307474
A Pilot Study of SBRT With Adjuvant Pazopanib for Renal Cell Cancer treatment Not Available withdrawn NCT05363631
Seleno-L Methionine (SLM)-Axitinib-Pembrolizumab treatment 1 / 2 recruiting NCT02923531
Addition of X4P-001 to Nivolumab Treatment in Participants With Renal Cell Carcinoma treatment 1 / 2 terminated NCT05286294
Microbiota Transplant to Cancer Patients Who Have Failed Immunotherapy Using Faeces From Clinical Responders treatment 2 recruiting NCT02837991
A Dose Escalation, Safety and Activity Study of CDX-014 in Patients With Renal Cell Carcinoma and Ovarian Clear Cell Carcinoma No drug interventions treatment 1 terminated NCT01157091
Pazopanib Hydrochloride in Treating Patients With Stage IV Kidney Cancer treatment 2 completed NCT04150562
Avelumab (Bavencio) With IL-15 in Subjects With Clear-Cell Renal Carcinoma treatment 2 terminated NCT02293980
A Phase 1, Dose-Escalation Trial of PT2385 Tablets In Patients With Advanced Clear Cell Renal Cell Carcinoma (MK-3795-001) treatment 1 active_not_recruiting NCT03682289
Ceralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients With Solid Tumors treatment 2 recruiting NCT04496089
Evaluation of Safety, Biodistibution and Sensitivity/Specificity of PET/CT Imaging With 89Zr-TLX250 in Subjects With RCC No drug interventions health_services_research 1 completed NCT03015740
Sitravatinib and Nivolumab in Treating Patients With Advanced or Metastatic Kidney Cancer treatment 1 / 2 completed NCT00112840
CCI-779 and Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney Cancer treatment 1 / 2 completed NCT04300140
Safety and Efficacy Study of AVB-S6-500 (Batiraxcept) in Patients With Advanced or Metastatic Clear Cell Renal Cell Carcinoma treatment 1 / 2 terminated NCT03280667
Denosumab and Pembrolizumab in Clear Cell Renal Carcinoma treatment 2 active_not_recruiting NCT01141569
A Study of RO4929097 in Patients With Advanced Renal Cell Carcinoma That Have Failed Vascular Endothelial Growth Factor (VEGF)/Vascular Endothelial Growth Factor Receptor (VEGFR) Therapy treatment 2 completed NCT04518046
Study of Sitravatinib, Nivolumab and Ipilimumab in Advanced or Metastatic Clear-Cell Renal Cell Carcinoma or Other Solid Malignancies treatment 1 completed NCT06559046
A CT-BASED Deep Learning Model for Predicting WHO/ISUP Pathological Grades of Clear Cell Renal Cell Carcinoma (ccRCC) :A Multicenter Cohort Study No drug interventions Not Available Not Available completed NCT05663710
Phase 1b/2 Study of Combination 177Lu Girentuximab Plus Cabozantinib and Nivolumab in Treatment naïve Patients With Advanced Clear Cell RCC treatment 1 / 2 active_not_recruiting NCT05879510
68Ga-NY104 PET/CT for the Detection of Clear Cell Renal Cell Carcinoma in Presurgical Patients With Renal Masses No drug interventions diagnostic 2 recruiting NCT01642095
Studying Biomarkers in Samples From Younger Patients With Kidney Cancer No drug interventions Not Available Not Available withdrawn NCT05795595
A Safety and Efficacy Study Evaluating CTX131 in Adult Subjects With Relapsed or Refractory Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT00101114
Sorafenib and Interferon Alfa in Treating Patients With Metastatic or Unresectable Kidney Cancer treatment 2 completed NCT02496208
Cabozantinib S-malate and Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Genitourinary Tumors treatment 1 active_not_recruiting NCT04022343
Neoadjuvant Cabozantinib in Treating Patients With Locally Advanced Kidney Cancer treatment 2 active_not_recruiting NCT06447103
An Investigational Scan (89Zr-DFO-GmAb PET/CT) Compared to Contrast-Enhanced CT for the Detection of Recurrent Clear Cell Renal Cell Cancer After Surgery Comparing Carbonic Anhydrase IX (CAIX) PET CT to Conventional PET CT for Post-Op Staging in Kidney Cancer diagnostic 2 recruiting NCT04627064
ABEMA Alone or in COMBO With MK-6482 treatment 1 active_not_recruiting NCT01158521
Pazopanib Hydrochloride Before Surgery in Treating Patients With Kidney Cancer treatment 2 completed NCT03680521
Neoadjuvant Sitravatinib in Combination With Nivolumab in Patients With Clear Cell Renal Cell Carcinoma treatment 2 completed NCT01497821
AMG 172 First in Human Study in Patients With Kidney Cancer No drug interventions treatment 1 completed NCT00408902
Tandutinib in Treating Patients Who Have Undergone Surgery for Metastatic Kidney Cancer treatment 2 completed NCT05581004
A Study to Evaluate the Safety, Pharmacokinetics, and Activity of RO7502175 as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Solid Tumors treatment 1 recruiting NCT01599754
Adjuvant Axitinib Therapy of Renal Cell Cancer in High Risk Patients prevention 3 terminated NCT02685553
Near Infrared Technology and Laparoscopic Resection of Pancreatic Lesions: the COLPAN Project No drug interventions diagnostic 1 completed NCT06221774
Safety and Efficacy of TT-00420 Tablets Combined With Toripalimab Injection in Advanced Urological Tumors treatment 1 / 2 not_yet_recruiting NCT01408004
Rotating Pazopanib and Everolimus to Avoid Resistance treatment 2 completed NCT06211790
Proteomic Guided First-line Precision Treatment of Renal Clear Cell Carcinoma treatment 2 recruiting NCT00397345
TroVax Renal Immunotherapy Survival Trial treatment 3 completed NCT04680416
Tissue Collection to ID TCRs From Renal Clear Cell Carcinoma Patients Responding to Immune Checkpoint Inhibitors No drug interventions Not Available Not Available withdrawn NCT02819596
MEDI4736 Combinations in Metastatic Renal Cell Carcinoma treatment 2 unknown_status NCT03066427
Study to Evaluate Efficacy and Safety of Sunitinib in Renal Cell Carcinoma Progressed to 1L Immunotherapy Treatment. treatment 2 completed NCT03556046
89Zr-girentuximab ) Dosimetry in CCRC Study - ZIR-DOSE No drug interventions diagnostic 1 completed NCT02348008
Phase Ib and Phase II Studies of MK-3475 in Combination + for Renal Cell Carcinoma: treatment 1 / 2 completed NCT02499458
Prospective Validation of Circulating Tumor Cells & Circulating Endothelial Cells as Biomarkers in Renal Cancer No drug interventions Not Available Not Available completed NCT00001238
Von Hippel-Lindau (VHL): Clinical Manifestations, Diagnosis, Management and Molecular Bases of Inherited Renal and Other Urologic Malignant Disorders No drug interventions Not Available Not Available recruiting NCT04802876
Efficacy of Tislelizumab and Spartalizumab Across Multiple Cancer-types in Patients With PD1-high mRNA Expressing Tumors treatment 2 recruiting